Southern Cross Healthcare has appointed Mike Bignall (pictured) as CEO for its Active+ joint venture. Bignall will succeed managing director Gill Webb, who will step down on June 30, after 30 years in her role.
As CEO, Bignall will lead both Active Physio Ltd (the physiotherapy franchising arm of Active+) and Active Ltd (the supply arm of Active+ of rehabilitation services).
Beginning July 01, Southern Cross Healthcare will hold all shares of Active Physio Ltd and the majority of shares in Active Ltd along with the other shareholders Andy Schmidt and Corne Mackie.
The business, which was founded by Webb in 1990, offers a range of preventative and rehabilitative services, including physiotherapy, occupational health, dietetics, psychology and counselling.
“My vision and passion for many years has been to create a holistic service to help get Kiwis back on their feet, and Active+ today is a reflection of that commitment,” said Webb in a statement.
“The time now feels right to let Active+ thrive under a new leadership and I couldn’t think of a better person to take on that role than Mike. He has proven business acumen and will bring a fresh energy to advance the Active+ offering in the community.”
Bignall has extensive experience in the healthcare sector, having held several management roles with ACC in rehabilitation services, partnerships and performance and health procurement. He has also worked for PHARMAC and the Ministry of Primary Industries.
“We’re grateful for Gill’s dedication and service to the business over the past three decades,” said Southern Cross Healthcare CEO Terry Moore. “She’s achieved admirable business growth and has made a huge impact in improving the rehabilitation needs of many New Zealanders. Gill will be missed by everyone who has had the pleasure of working with her, and on behalf of everyone at Active+, I wish her all the best.
“We also look forward to welcoming Mike to Active+. He’ll be working closely with Gill before she finishes in June to ensure a seamless leadership transition for all Active+ clinicians and patients.”
